Commentary II - The journal impact factor in the evaluation of research quality: villain, scapegoat or innocent bystander?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preeclampsia and subsequent cardiovascular disease: villain or innocent bystander?

Not long ago, women who experienced preeclampsia were reassured that there were no long-term health risks associated with their condition—with the notable exception of an increased risk of recurrent preeclampsia in future pregnancies. Although proteinuria and hypertension would sometimes take weeks or even months to resolve, spontaneous remission after delivery was the rule. Although preexistin...

متن کامل

Insulin and atherosclerosis: villain, accomplice, or innocent bystander?

Initial descriptions of an association between insuli-naemia and both atherosclerotic cardiovascular disease and its risk factors appeared nearly 30 years ago. In 1969, Stout and Vallance-Owen suggested a direct role for insulin in atherogenesis.' Stout recently summarised laboratory studies supporting a direct atherogenic effect of insulin through stimulation of vascular smooth muscle prolifer...

متن کامل

the impact of e-readiness on ec success in public sector in iran the impact of e-readiness on ec success in public sector in iran

acknowledge the importance of e-commerce to their countries and to survival of their businesses and in creating and encouraging an atmosphere for the wide adoption and success of e-commerce in the long term. the investment for implementing e-commerce in the public sector is one of the areas which is focused in government‘s action plan for cross-disciplinary it development and e-readiness in go...

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Sozial- und Pr�ventivmedizin/Social and Preventive Medicine

سال: 2004

ISSN: 0303-8408,1420-911X

DOI: 10.1007/s00038-003-0033-2